127 related articles for article (PubMed ID: 32273131)
1. Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer.
Ben Yahia H; Boujelbene N; Babay W; Ben Safta I; Dhouioui S; Zemni I; Ali Ayadi M; Charfi L; Ouzari HI; Rebmann V; Rizzo R; Mrad K; Driss M; Zidi I
Hum Immunol; 2020 Jun; 81(6):305-313. PubMed ID: 32273131
[TBL] [Abstract][Full Text] [Related]
2. HLA-G, HLA-E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma.
Boujelbene N; Ben Yahia H; Babay W; Gadria S; Zemni I; Azaiez H; Dhouioui S; Zidi N; Mchiri R; Mrad K; Ouzari HI; Charfi L; Zidi I
HLA; 2019 Jul; 94(1):11-24. PubMed ID: 30907063
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
[TBL] [Abstract][Full Text] [Related]
4. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival.
Ino K; Yamamoto E; Shibata K; Kajiyama H; Yoshida N; Terauchi M; Nawa A; Nagasaka T; Takikawa O; Kikkawa F
Clin Cancer Res; 2008 Apr; 14(8):2310-7. PubMed ID: 18413819
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.
Sideras K; Biermann K; Yap K; Mancham S; Boor PPC; Hansen BE; Stoop HJA; Peppelenbosch MP; van Eijck CH; Sleijfer S; Kwekkeboom J; Bruno MJ
Int J Cancer; 2017 Aug; 141(3):572-582. PubMed ID: 28470686
[TBL] [Abstract][Full Text] [Related]
6. IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G.
Jing R; Bai S; Zhang P; Ren H; Jia L; Li W; Zheng G
Breast Cancer; 2024 Jan; 31(1):135-147. PubMed ID: 37981615
[TBL] [Abstract][Full Text] [Related]
7. Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer.
Mariya T; Kubo T; Hirohashi Y; Yanagawa J; Tabuchi Y; Matsuo K; Furumura K; Morita R; Nakatsugawa M; Kanaseki T; Tsukahara T; Hasegawa T; Saito T; Torigoe T
Med Mol Morphol; 2021 Mar; 54(1):14-22. PubMed ID: 32410009
[TBL] [Abstract][Full Text] [Related]
8. Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas.
de Jong RA; Boerma A; Boezen HM; Mourits MJ; Hollema H; Nijman HW
Int J Cancer; 2012 Oct; 131(8):1828-36. PubMed ID: 22287095
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen-G (HLA-G) expression plays an important role in the diagnosis and grading of endometrial cancer.
Bai Y; Liu W; Xie Y; Liang J; Wang F; Li C
J Obstet Gynaecol; 2022 May; 42(4):641-647. PubMed ID: 34382498
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma.
de Jong RA; Kema IP; Boerma A; Boezen HM; van der Want JJ; Gooden MJ; Hollema H; Nijman HW
Gynecol Oncol; 2012 Sep; 126(3):474-80. PubMed ID: 22668882
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.
Babay W; Ben Yahia H; Boujelbene N; Zidi N; Laaribi AB; Kacem D; Ben Ghorbel R; Boudabous A; Ouzari HI; Rizzo R; Rebmann V; Mrad K; Zidi I
Hum Immunol; 2018 Jun; 79(6):463-470. PubMed ID: 29499226
[TBL] [Abstract][Full Text] [Related]
13. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
14. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
Versluis MAC; Marchal S; Plat A; de Bock GH; van Hall T; de Bruyn M; Hollema H; Nijman HW
Eur J Cancer; 2017 Nov; 86():285-295. PubMed ID: 29059634
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
16. Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages.
López AS; Alegre E; Díaz-Lagares A; García-Girón C; Coma MJ; González A
Immunol Lett; 2008 Apr; 117(1):91-5. PubMed ID: 18289708
[TBL] [Abstract][Full Text] [Related]
17. The analysis of human leukocyte antigen-G level in patients with endometrial cancer by Western blot technique.
Walentowicz-Sadlecka M; Dziobek K; Grabiec M; Sadlecki P; Walentowicz P; Mak P; Szymankiewicz M; Kwinta P; Dutsch-Wicherek M
Am J Reprod Immunol; 2019 Jan; 81(1):e13070. PubMed ID: 30414280
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
[TBL] [Abstract][Full Text] [Related]
20. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
